Emverm Approval History
- FDA approved: Yes (First approved January 15th, 2016)
- Brand name: Emverm
- Generic name: mebendazole
- Dosage form: Chewable Tablets
- Company: Impax Pharmaceuticals
- Treatment for: Pinworm Infection (Enterobius vermicularis), Whipworm Infection, Hookworm Infection (Necator or Ancylostoma), Ascariasis
Emverm (mebendazole) is a chewable tablet formulation of the approved anthelmintic mebendazole for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.
Development History and FDA Approval Process for Emverm
|Jan 18, 2016||Impax Receives Approval of Emverm (mebendazole) Chewable Tablets|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.